January 27, 2012 - publisher
Stocks continue to chop along with mixed results. Materials stocks, now up 0.3%, have been joined in positive territory by tech stocks, which are collectively up just 0.1%. Every other sector remains mired in negative territory.
The final reading on consumer sentiment for January from the University of Michigan improved to 75.0 from the 74.0 that was recored in the preliminary reading. Economists polled by Briefing.com had expected, on average, that the reading would inch up to 74.2.
HEB – Trade Alert
Up 16.72% in morning trading to $.37 with 350K shares traded
Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx’s flagship products include Alferon N Injection(R) (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen(R) and Alferon(R) LDO. Ampligen(R) is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system. Hemispherx’s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection(R)). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products. Hemispherx Biopharma, Inc. (NYSE Amex:HEB) yesterday announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, has approved the sale and distribution of Alferon N Injection(R) (under the brand name “Naturaferon”) in Argentina.
To Read Full Story go to: http://www.pennytrader.com/quotes/HEB.php
(more…)
January 26, 2012 - publisher
Selling pressure has picked up in recent trade, resulting in a loss for both the S&P 500 and the Nasdaq after each had traded with a solid gain in the early going. The Dow is at a session low, but it has managed to remain in positive territory with help from 3M (MMM 87.40, +0.92) and Caterpillar (CAT 112.67, +3.62), both of which bested expectations for the bottom line of their latest quarterly reports. However, their strength is being partly offset by weakness in AT&T (T 29.47, -0.74), which posted earnings that came short of the consensus estimate.
CBIS – Trade Alert
Up 14.71% in morning trading to $.05 with 5M shares traded
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Cannabis Science, Inc. (OTCBB: CBIS) yesterday inform that the current progress and success with their numerous self-medicated cancer patients, has lead the Company to immediately begin the Investigational New Drug (IND) application process that will target cancer treatment.
To Read Full Story go to: http://www.pennytrader.com/quotes/CBIS.php
(more…)
January 25, 2012 - publisher
The broad market remains in negative territory, unfased by the latest monthly pending home sales numbers. Pending home sales for December fell 3.5%, which is worse than the 3.0% decline that had been expected, on average, among economists polled by Briefing.com.
The pending home sales report is the first piece of concrete economic data released this week, but the highlighting event of today’s calendar is the FOMC Policy Statement at 2:00 PM ET.
ATTD – Trade Alert
Up 63.89% in morning trading to $.0059 with 51M shares traded
Attitude Drinks Inc. is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III® is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. Attitude Drinks (OTC.BB: ATTD) (OTCQB: ATTD.OB) yesterday announced a sales agreement with Walgreens, of Deerfield, IL.
To Read Full Story go to: http://www.pennytrader.com/quotes/ATTD.php
(more…)
January 24, 2012 - publisher
The stock market has run into renewed selling pressure, cutting its climb short of positive territory. There isn’t any direct headline to account for the interruption.
However, the euro, which has shared a positive correlation with the stock market for several months, has paused just below the flat line after it, too, had spent most of the morning working its way up from a marked loss. The euro now trails the dollar by only 0.1%.
ECIT – Trade Alert
Up 78.11% in morning trading to $.415 with 5M shares traded
Ecoland International Inc. trades in Bat Guano, an organic fertilizer. In a growing organic foods market and gardening, the market for fertilizer has grown and makes up a growing percentage of the outdoor living market. D & R Technology Inc., a wholly owned subsidiary of Ecoland International, Inc. (OTCBB:ECIT), one of North America’s fastest growing applied-robotics companies, announced today the receipt of a tooling contract from Toyota Boshoku (Pink Sheets:TDBOF), a major tier one automotive parts supplier.
To Read Full Story go to: http://www.pennytrader.com/quotes/ECIT.php
(more…)
January 23, 2012 - publisher
Stocks recently turned lower after failing to extend their opening climb. Financials and tech issues had been a source of leadership, but strength in the two sectors has been checked in recent trade.
The stock market’s slip comes even though the euro has continued to climb against the greenback. The euro is now up 1.3% to $1.305, which makes for its best level in nearly three weeks.
IVOB – Trade Alert
Up 55.94% in morning trading to $.0499 with 1M shares traded
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company’s lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman’s vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience, Inc. (OTC BB: IVOB) Friday announced that the National Health Surveillance Agency (ANVISA) in Brazil has granted approval of the INVOcell for use as a Class II device.
To Read Full Story go to: http://www.pennytrader.com/quotes/IVOB.php
(more…)
